October 26, 2001
AmeriPath to Present at Health Care Conference

FOR IMMEDIATE RELEASE

Contact: Gregory A. Marsh Michelle D. Getty Vice President & CFO Investor Relations AmeriPath, Inc. AmeriPath, Inc. 561-712-6211 561-712-6260 E-mail: invrel@ameripath.com

AMERIPATH, INC. TO PRESENT AT THE SALOMON SMITH BARNEY 2001 HEALTHCARE CONFERENCE James C. New, Chairman & CEO, October 29, 2001 at 4:00 p.m. Eastern Time

Riviera Beach, FL, October 26, 2001 - AmeriPath, Inc. (Nasdaq:PATH), the largest physician and laboratory company focused on providing anatomic pathology, cancer diagnostic, genomics, and healthcare information services, today announced it will participate in the Salomon Smith Barney 2001 Healthcare Conference to be held at the The Plaza Hotel in New York City, New York. The AmeriPath presentation will be made by the Company's Chairman and Chief Executive Officer, James C. New on Monday, October 29, 2001, at 4:00 p.m. Eastern Time.

The conference, including the AmeriPath presentation, will be webcast live on the Internet. The web link is http://www.veracast.com/clientaccess/ssb/healthcare-2001/73115334.cfm, and will be available on the Investor Relations page of the AmeriPath website, http://www.ameripath.com. The AmeriPath presentation can be accessed for replay on the AmeriPath website until November 29, 2001.

AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. The Company's extensive diagnostics infrastructure includes 425 pathologists and doctorate-level scientists, 42 independent pathology laboratories, the Center for Advanced Diagnostics (CAD), and Dermpath Diagnostics. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics, Cytogenetics, and HPV Typing. Dermpath Diagnostics, with 68 board-certified dermatopathologists, is the country's leading provider of dermatopathology services in the growing skin diagnostic testing market. Additionally, AmeriPath provides clinical trial and research and development support to firms involved in developing new cancer and genomic diagnostic and therapeutics.